检索结果 - Hasan Ahmad Hasan Albitar

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers

    Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers 由 Hanny Al‐Samkari, Hasan Ahmad Hasan Albitar, Scott E. Olitsky, Marianne S. Clancy, Vivek N. Iyer

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study

    An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study 由 Hanny Al‐Samkari, Raj S. Kasthuri, Joseph G. Parambil, Hasan Ahmad Hasan Albitar, Yahya Almodallal, Carolina Vázquez, Marcelo M. Serra, Sophie Dupuis‐Girod, C.B. Wilsen, Justin P. McWilliams, Evan H. Fountain, James R. Gossage, Clifford R. Weiss, Muhammad Latif, Assaf Issachar, Meir Mei‐Zahav, Mary E. Meek, Miles Conrad, Josanna Rodriguez‐Lopez, David J. Kuter, Vivek N. Iyer

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: